These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 8510922)

  • 21. Functional analysis of the SH2 and SH3 domains of the lck tyrosine protein kinase.
    Reynolds PJ; Hurley TR; Sefton BM
    Oncogene; 1992 Oct; 7(10):1949-55. PubMed ID: 1408136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An intramolecular SH3-domain interaction regulates c-Abl activity.
    Barilá D; Superti-Furga G
    Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
    Van Etten RA; Debnath J; Zhou H; Casasnovas JM
    Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G; Gilmore TD
    Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of a novel isoform of Vav, Vav-T, containing a single Src homology 3 domain in murine testicular germ cells.
    Okumura K; Kaneko Y; Nonoguchi K; Nishiyama H; Yokoi H; Higuchi T; Itoh K; Yoshida O; Miki T; Fujita J
    Oncogene; 1997 Feb; 14(6):713-20. PubMed ID: 9038379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
    Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
    J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
    Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH
    Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
    Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
    Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
    Summy JM; Guappone AC; Sudol M; Flynn DC
    Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
    Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT
    Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
    Potts WM; Reynolds AB; Lansing TJ; Parsons JT
    Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of structure and activation of some receptor-type tyrosine kinase oncogenes.
    Shibuya M; Matsushime H; Yamazaki H; Wang LH; Fukui Y; Ueyama Y; Tamaoki N
    Princess Takamatsu Symp; 1986; 17():195-202. PubMed ID: 3455414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells.
    Ogawa S; Toyoshima H; Kozutsumi H; Hagiwara K; Sakai R; Tanaka T; Hirano N; Mano H; Yazaki Y; Hirai H
    Oncogene; 1994 Jun; 9(6):1669-78. PubMed ID: 8183562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding in vitro of phosphotyrosine-containing proteins to pp60c-src SH2 domain does not correlate with CEF transformation.
    Boeuf H; Murphy J; Bibbins KB; Varmus HE
    Oncogene; 1995 Feb; 10(3):433-8. PubMed ID: 7531318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neu and its ligands: from an oncogene to neural factors.
    Peles E; Yarden Y
    Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic activation of v-kit involves deletion of a putative tyrosine-substrate interaction site.
    Herbst R; Munemitsu S; Ullrich A
    Oncogene; 1995 Jan; 10(2):369-79. PubMed ID: 7530827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly conserved amino acids in the SH2 and catalytic domains of v-src are altered in naturally occurring, transformation-defective alleles.
    Verderame MF; Varmus HE
    Oncogene; 1994 Jan; 9(1):175-82. PubMed ID: 8302576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav.
    Tarakhovsky A; Turner M; Schaal S; Mee PJ; Duddy LP; Rajewsky K; Tybulewicz VL
    Nature; 1995 Mar; 374(6521):467-70. PubMed ID: 7700358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.